Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma–associated herpesvirus
- 15 November 2001
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 98 (10), 3042-3049
- https://doi.org/10.1182/blood.v98.10.3042
Abstract
Receptor usage by viral interleukin-6 (vIL-6), a virokine encoded by Kaposi sarcoma– associated herpesvirus, is an issue of controversy. Recently, the crystal structure of vIL-6 identified vIL-6 sites II and III as directly binding to glycoprotein (gp)130, the common signal transducer for the IL-6 family of cytokines. Site I of vIL-6, however, comprising the outward helical face of vIL-6, where human IL-6 (hIL-6) would interact with the specific α-chain IL-6 receptor (IL-6R), is accessible and not occupied by gp130. This study examined whether this unused vIL-6 surface is available for IL-6R binding. By enzyme-linked immunosorbent assay, vIL-6 bound to soluble gp130 (sgp130) but not to soluble IL-6R (sIL-6R). Using plasmon surface resonance, vIL-6 bound to sgp130 with a dissociation constant of 2.5 μM, corresponding to 1000-fold lower affinity than that of hIL-6/sIL-6R complex for gp130. sIL-6R neither bound to vIL-6 nor affected vIL-6 binding to gp130. In bioassays, vIL-6 activity was neutralized by 4 monoclonal antibodies (mAbs) recognizing a domain within vIL-6 site I, mapped to the C-terminal part of the AB-loop and the beginning of helix B. The homologous region in hIL-6 participates in site I binding to IL-6R. In addition, binding of vIL-6 to sgp130 was interfered with specifically by the 4 neutralizing anti–vIL-6 mAbs. Based on the vIL-6 crystal structure, the vIL-6 neutralizing mAbs map outside the binding interface to gp130, suggesting that they either produce allosteric changes or block necessary conformational changes in vIL-6 preceding its binding to gp130. These results document that vIL-6 does not bind IL-6R and suggest that conformational change may be critical to vIL-6 function.This publication has 48 references indexed in Scilit:
- Detection of Direct Binding of Human Herpesvirus 8-Encoded Interleukin-6 (vIL-6) to both gp130 and IL-6 Receptor (IL-6R) and Identification of Amino Acid Residues of vIL-6 Important for IL-6R-Dependent and -Independent SignalingJournal of Virology, 2001
- Structural and Functional Studies with Antibodies to the Integrin β2 SubunitOnline Journal of Public Health Informatics, 2000
- Viral G Protein–Coupled Receptor and Kaposi's SarcomaThe Journal of Experimental Medicine, 2000
- Molecular Modeling-guided Mutagenesis of the Extracellular Part of gp130 Leads to the Identification of Contact Sites in the Interleukin-6 (IL-6)·IL-6 receptor·gp130 ComplexOnline Journal of Public Health Informatics, 1997
- Conformational Changes in G-CSF/Receptor Complex As Investigated by Isotope-Edited FTIR SpectroscopyBiochemistry, 1997
- gp130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINESAnnual Review of Immunology, 1997
- Characterization of an Interleukin 6 Cytokine Family Antagonist Protein from a Marine Sponge, Callyspongia sp.Online Journal of Public Health Informatics, 1996
- Infection of human endothelial cells with Epstein-Barr virus.The Journal of Experimental Medicine, 1995
- Human and Viral Interleukin-10 in Acute Epstein-Barr Virus-Induced Infectious MononucleosisThe Journal of Infectious Diseases, 1995
- Molecular cloning and expression of an IL-6 signal transducer, gp130Cell, 1990